Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Chinese Patent Office
Medtronic
Citi
UBS
Merck
Argus Health
Boehringer Ingelheim
Covington

Generated: January 20, 2018

DrugPatentWatch Database Preview

PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Plasma-lyte 148 And Dextrose 5% In Plastic Container, and when can generic versions of Plasma-lyte 148 And Dextrose 5% In Plastic Container launch?

Plasma-lyte 148 And Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
Summary for PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 017451-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Healthtrust
McKinsey
Chinese Patent Office
Boehringer Ingelheim
US Army
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot